Xanthohumol enhances antiviral effect of interferon α-2b against bovine viral diarrhea virus, a surrogate of hepatitis C virus

Phytomedicine

Volumn 17, Issue 5, 2010, Pages 310-316

  Zhang, Ni ^a   Liu, Zhengwen ^a   Han, Qunying ^a   Chen, Jinghong ^b   Lv, Yi ^a  

^a First Affiliated Hospital   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Bovine viral diarrhea virus; Hepatitis C virus; Interferon 2b; Orthogonal design; Xanthohumol

Indexed keywords

ALPHA2B INTERFERON; GLYCOPROTEIN E2; VIRUS RNA; XANTHOHUMOL;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BOVINE DIARRHEA VIRUS; CONTROLLED STUDY; DRUG POTENTIATION; HEPATITIS C VIRUS; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CATTLE; CELL LINE; CYTOPATHOGENIC EFFECT, VIRAL; DIARRHEA VIRUSES, BOVINE VIRAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FLAVIVIRIDAE INFECTIONS; FLAVONOIDS; HEPACIVIRUS; HUMULUS; INTERFERON ALFA-2B; MALE; PHYTOTHERAPY; PLANT EXTRACTS; PROPIOPHENONES; RNA, VIRAL; TESTIS; VIRAL ENVELOPE PROTEINS;

BOVINE VIRAL DIARRHEA VIRUS 1; HEPATITIS C VIRUS;

EID: 77049088673     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2009.08.005     Document Type: Article

References (37)

1. Archer C.B., Frohlich W., Page C.W., Paul W., Morley J., and MacDonald D.M. Synergistic interaction between prostaglandins and PAF-acether in experimental animals and man. Prostaglandins 27 (1984) 495-501
2. Berenbaum M.C. Criteria for analyzing interactions between biologically active agents. Adv. Cancer Res. 35 (1981) 269-335
3. Berenbaum M.C. What is synergy?. Pharmacol Rev 41 (1989) 93-141
4. Buckwold V.E., Wei J., Wenzel-Mathers M., and Russell J. Synergistic in vitro interactions between alpha interferon and RBV against bovine viral diarrhea virus and yellow fever virus as surrogate models of hepatitis C virus replication. Antimicrob. Agents Chemother. 47 (2003) 2293-2298
5. Buckwold V.E., Beer B.E., and Donis R.O. Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents. Antiviral Res. 60 (2003) 1-15
6. Buckwold V.E., Wilson R.J., Nalca A., Beer B.B., Voss T.G., Turpin J.A., Buckheit III R.W., Wei J., Wenzel-Mathers M., Walton E.M., Smith R.J., Pallansch M., Ward P., Wells J., Chuvala L., Sloane S., Paulman R., Russell J., Hartman T., and Ptak R. Antiviral activity of hop constituents against a series of DNA and RNA viruses. Antiviral Res. 61 (2004) 57-62
7. Casaschi A., Maiyoh G.K., Rubio B.K., Li R.W., Adeli K., and Theriault A.G. The chalcone xanthohumol inhibits triglyceride and apolipoprotein B secretion in HepG2 cells. J. Nutr. 134 (2004) 1340-1346
8. Crotty S., Cameron C.E., and Andino R. RNA virus error catastrophe: direct molecular test by using ribavirin. Proc. Natl. Acad. Sci. USA 98 (2001) 6895-6900
9. Durantel D., Branza-Nichita N., Carrouee-Durantel S., Butters T.D., Dwek R.A., and Zitzmann N. Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus. J. Virol. 75 (2001) 8987-8998
10. Durantel D., Carrouée-Durantel S., Branza-Nichita N., Dwek R.A., and Zitzmann N. Effects of interferon, ribavirin, and iminosugar derivatives on cells persistently infected with noncytopathic bovine viral diarrhea virus. Antimicrob. Agents Chemother. 48 (2004) 497-504
11. Fronhoffs S., Totzke G., Stier S., Wernert N., Rothe M., Brüning T., Koch B., Sachinidis A., Vetter H., and Ko Y. A method for the rapid construction of cRNA standard curves in quantitative real-time reverse transcription polymerase chain reaction. Mol. Cell Probes 16 (2002) 99-110
12. Fried M.W., Shiffman M.L., Reddy K.R., Smith C., Marinos G., Gonçales Jr. F.L., Häussinger D., Diago M., Carosi G., Dhumeaux D., Craxi A., Lin A., Hoffman J., and Yu J. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 347 (2002) 975-982
13. Goodbourn S., Didcock L., and Randall R.E. Interferons: cell signaling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 81 (2000) 2341-2364
14. Greiser-Wilke I., Dittmar K.E., Liess B., and Moennig V. Immunofluorescence studies of biotype-specific expression of bovine viral diarrhea virus epitopes in infected cells. J. Gen. Virol. 72 (1991) 2015-2019
15. Heo D.S., Park J., Hata K., Day R., Herberman R.B., and Whiteside T.L. Evaluation of tetrazolium based semiautomatic colorimetric assay for measurement of human ant-tumor cytotoxicity. Cancer Res. 50 (1990) 3681-3690
16. Hultgren C., Milich D.R., Weiland O., and Sällberg M. The antiviral compound ribavirin modulates the T helper (Th)1/Th2 subset balance in hepatitis B and C virus-specific immune responses. J. Gen. Virol. 79 (1998) 2381-2391
17. Kempthome O., 1952. In: O. Kempthome (Ed.), The Design and Analysis of Experiments, first ed. John Wiley and Sons, Inc., New York, p. 631
18. Liang T.J., Rehermann B., Seeff L.B., and Hoofnagle J.H. Pathogenesis, natural history, treatment and prevention of hepatitis C. Ann. Intern. Med. 132 (2000) 296-305
19. Maag D., Castro C., Hong Z., and Cameron C.E. Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin. J. Biol. Chem. 276 (2001) 46094-46098
20. Manns M.P., McHutchison J.G., Gordon S.C., Rustgi V.K., Shiffman M., Reindollar R., Goodman Z.D., Koury K., Ling M., and Albrecht J.K. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 358 (2001) 958-965
21. Miller R.H., and Purcell R.H. Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc. Natl. Acad. Sci. USA 87 (1990) 2057-2061
22. Miranda C.L., Stevens J.F., Helmrich A., Henderson M.C., Rodriguez R.J., Yang Y.H., Deinzer M.L., Barnes D.W., and Buhler D.R. Antiproliferative and cytotoxic effects of prenylated flavonoids from Hop (Humulus lupulus) in human cancer cell lines. Food Chem. Toxicol. 37 (1999) 271-285
23. McHutchison J.G., Gordon S.C., Schiff E.R., Shiffman M.L., Lee W.M., Rustgi V.K., Goodman Z.D., Ling M.H., Cort S., and Albrecht J.K. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N. Engl. J. Med. 339 (1998) 1485-1492
24. Nahmias Y., Goldwasser J., Casali M., Poll D.V., Wakita T., Chung R.T., and Yarmush M.L. Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin. Hepatology 47 (2008) 1437-1445
25. Nozawa H. Xanthohumol, the chalcone from beer hops (Humulus lupulus L.), is the ligand for farnesoid X receptor and ameliorates lipid and glucose metabolism in KK-Ay mice. Biochem. Biophys. Res. Commun. 336 (2005) 754-761
26. Ouzounov S., Mehta A., Dwek R.A., Block T.M., and Jordan R. The combination of interferon alpha-2b and n-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: implications for hepatitis C virus (HCV) therapy. Antiviral Res. 55 (2002) 425-435
27. Reed L.J., and Muench A.H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27 (1938) 493-497
28. Sentsui H., Takami R., Nishimori T., Murakami K., Yokoyama T., and Yokomizo Y. Anti-viral effect of interferon-alpha on bovine viral diarrhea virus. J. Vet. Med. Sci. 60 (1998) 1329-1333
29. Shanghai Scientific and Technique Interchange Station (Ed.), 1975. Method-Factorial Experimental Design, first ed. Shanghai People's Publishing House, Shanghai
30. Sladowski D., Steer S.J., Clothier R.H., and Balls M. An improved MTT assay. J. Immunol. Methods 157 (1993) 203-207
31. Sun J.H., Lemm J.A., O'Boyle II D.R., Racela J., Colonno R., and Gao M. Specific inhibition of bovine viral diarrhea virus replicase. J. Virol. 77 (2003) 6753-6760
32. Standardization Administration of the People's Republic of China, 2004. National standards of the P.R.C., diagnostic techniques for bovine viral diarrhea/mucosal disease. In: First Editing Room of Standards Press of China (Ed.), Collection of National Animal Health Standardizatio, first ed. Standards Press of China, BeiJing, pp. 127-133.
33. Stuyver L.J., Whitaker T., McBrayer T.R., Hernandez-Santiago B.I., Lostia S., Tharnish P.M., Ramesh M., Chu C.K., Jordan R., Shi J., Rachakonda S., Watanabe K.A., Otto M.J., and Schinazi R.F. Ribonucleoside analogue that blocks replication of bovine viral diarrhea and hepatitis C viruses in culture. Antimicrob. Agents Chemother. 47 (2003) 244-254
34. Takeuchi H., Baba M., and Shigeta S. An application of tetrazolium (MTT) colorimetric assay for the screening of anti-herpes simplex virus compounds. J. Virol. Methods 33 (1991) 661-671
35. Wagner H., and Ulrich-Merzenich G. Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine 16 (2009) 97-110
36. Wasley A., and Alter M.J. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis. 20 (2000) 1-16
37. Zhou S., Liu R., Baroudy B.M., Malcolm B.A., and Reyes G.R. The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA. Virology 310 (2003) 333-342